Regenica® was developed by Dr. Gail Naughton, who was one of the original developers of TNS® growth factor technology in the 1990s. As she continued to advance her research over the next two decades, she was struck by the fact that an unborn child could have surgery, yet have no scars at birth. She studied what was unique about the prenatal environment and found a way to mimic it, so that she could produce the same type of multipotent growth factors that are associated with scarless healing.
Regenica® was developed using the latest technological and scientific methods. The proprietary, patented conditioning process uses only pure nutrients and no bovine serum.
While conventional culturing techniques use atmospheric oxygen levels, Regenica® creates an embryonic-like environment by reducing oxygen levels and maintaining the cells in suspension with constant, gentle motion.
This process enhances the cells to revert back to an earlier state, behave like stem cells, and release multipotent growth factors that are unlike those in any other growth factor product.